Posted on December 15, 2020 by Aaron Warwick
This morning Raymond James in Canda initiated coverage of Protech Home Medical (PTQQF or PTQ.V) with an outperform rating and a price target of $2.00 Canadian dollars. That price target represents about 40% upside from its closing price the day before of $1.44 on the Toronto exchange. Shares on both the US OTC and Toronto exchanges have been up around 5% throughout the day following this initiation report. I have written fairly extensively on PTQQF, including an update on this website yesterday, in tandem with the publication of a full article on Seeking Alpha. I plan to continue coverage of this stock on my Breakout Investor page as I believe the stock has much more upside than even the Raymond James report indicates.
Disclosure: I am long PTQQF and may buy or sell shares at any time.